Healthcare | August 28, 2023
IBL Healthcare invests in KNISS Laboratories
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Need to harmonize traditional and modern medicine to combat alarming health problems
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
